I know some may not like the smell, these products do not contain perfumes
Payers should collaborate with plan sponsors, PBMs, manufacturers and providers to expand GLP-1 coverage: Payers have a key role in realizing GLP-1 cost savings as well as ensuring equitable, affordable access and quality of care by collaborating with PBMs, GLP-1 manufacturers and plan sponsors to expand GLP-1 coverage while driving down costs
There is no fixed conversion chart, but in general: 0.25mg0.5mg for someone whose been on lower Mounjaro doses (2.5mg5mg), 0.5mg1mg for mid-range doses (7.5mg10mg), and 1mg for higher doses (12.5mg15mg)
We do not dispense Zepbound or Mounjaro, which are brand-name tirzepatide products manufactured by Eli Lilly and Company
While headache is reported as an adverse reaction, it is not listed among the most common adverse events in the FDA Prescribing Information for Ozempic